News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Drug Product News
BioPharm Executive: Have Drugs Finally Been Priced Too High? 7/31/2014
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M 7/31/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
GlaxoSmithKline (GSK)'s Tanzeum™ Is Now Available In Pharmacies In The U.S. 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Akrimax Pharmaceuticals Initiates CONTROL Patient Registry For Tirosint® (Levothyroxine Sodium) Capsules 7/29/2014
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E 7/24/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Announces Direct US Marketing-Sales Campaign For New i-Lid™ Cleanser Product 7/16/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
Celsion Corporation (CLN) Announces Commercialization Of Reagent Products 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014
Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014
Insight Pharmaceuticals Release: MONISTAT® Announces New Suite Of Complete Care™ Products 7/9/2014
Par Pharmaceutical, Inc. Begins Shipment Of Fluphenazine Decanoate Injection, USP 7/9/2014
Skystar Bio-Pharmaceutical (CGPN) Launches Bovine Immunoglobulin G (IgG) Kits In China 7/8/2014
Perrigo Company (PRGO) Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg 7/8/2014
Mylan Inc. (MYL) Launches Generic Micardis® Tablets 7/8/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Upsher-Smith Laboratories Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations 7/2/2014
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Updated Labeling For Gattex® (Teduglutide [RDNA Origin]) For Injection To Include Long-Term Data 6/30/2014
Aqua Pharmaceuticals Announces Launch Of Cordran® Ointment (Flurandrenolide Ointment, USP) 0.05% 6/30/2014
Upsher-Smith Laboratories Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types 6/30/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Duloxetine Delayed-Release Capsules USP 6/27/2014
Ohm Laboratories, Inc. To Launch Valsartan Tablets 6/27/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Quest Products, Inc. Introduces New ProVent® Eczema And Psoriasis Spray® 6/25/2014
Hetero Launches Darbepoetin Alfa, A Much Needed Biosimilar Anemia Treatment In India 6/19/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
Manzo Pharmaceuticals Announces The Release Of Its Newest Product Tummy Relief A Natural Colic Remedy For Babies 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
DermWorx Incorporated / LETI Laboratories S.L. To Launch Leading Atopic Skincare Line To The U.S. Market 6/17/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In The United Kingdom 6/16/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
MediGene AG (MDGEF.PK) Announces Market Launch Of Veregen®: In Belgium, Denmark And Finland 6/12/2014
Mylan Inc. (MYL) Launches Generic Actonel® Tablets, 150 mg 6/11/2014
Auxilium Pharmaceuticals (AUXL) Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel) 6/11/2014
Forest Laboratories, Inc. (FRX) Announces Intention To Continue Marketing Both NAMENDA® TABLETS And Once-Daily NAMENDA XR® Into The Fall Of 2014 6/11/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Mylan Inc. (MYL) Launches Generic Paraplatin® Injection 6/9/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Paragon BioTeck Announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available 6/4/2014
CorePharma LLC Announces The Launch Of Dextroamphetamine Sulfate Tablets, USP 6/4/2014
Norgen Biotek Corporation Launches 6 Novel Kits For The Isolation Of High-Quality Circulating Nucleic Acids From Blood, Plasma, Serum And Urine 6/4/2014
H2-Pharma Launches Authorized Generic LIPOFEN 6/3/2014
Gilead Sciences Canada, Inc. (GILD) Release: Quebec Becomes First Province To Reimburse Sovaldi® For The Treatment Of Chronic Hepatitis C 6/3/2014
Mission Pharmacal Company Begins Exclusive Promotion Of Elestrin® (Estradiol Gel) 0.06% In The U.S. Market 5/30/2014
Mylan Inc. (MYL) Launches Generic Malarone® Tablets 5/29/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Pfizer Inc. (PFE) Brings Frequent Heartburn Relief Over-The-Counter With New Nexium® 24HR 5/27/2014
Solara Labs Announces The Launch Of BariMelts® 5/27/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
DiscoveRx Corporation Enables Predictive In Vitro Drug Combination Studies With Launch Of Biomap® Combo ELECT 5/21/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
ALK-Abello A/S's Partner For North America, Merck & Co., Inc. (MRK), Announces Launch Of RAGWITEK™ In Canada 5/15/2014
Negative National Institute for Clinical Excellence (NICE) Draft Guidance On Janssen Biotech Inc. (JNJ)'s Zytiga For Prostate Cancer 5/14/2014
Mylan Inc. (MYL) Launches Generic Zyprexa Zydis® Tablets 5/14/2014
INSYS Therapeutics Issues Clarifying Statement 5/13/2014
Veracyte, Inc. (VCYT) Launches Afirma® Malignancy Classifiers To Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries And Lower Healthcare Costs 5/13/2014
Ipsen (IPN.PA) Announces A Step Forward In The Resupply Of Increlex® (Mecasermin [rDNA Origin] Injection) In The U.S. 5/13/2014
Ajanta Pharma Announces The Launch Of Risperidone Tablets 5/9/2014
CorePharma LLC Launches Methylphenidate Hydrochloride Tablets USP 5/8/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
Cumberland Pharmaceuticals (CPIX) Launches Vaprisol® Promotion 5/7/2014
Greer Labs Launches ORALAIR®, The First And Only Sublingual Allergy Immunotherapy Tablet With A Mix Of Five Grass Allergens For The Treatment Of Grass Pollen Allergy 5/5/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Covance Inc. (CVD) Launches New Brand: Solutions Made Real™ 5/2/2014
Access Pharmaceuticals (ACCP) MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer 5/1/2014
MyoScience Inc. Release: Novel Pain Treatment Is Now Available: Iovera System Harnesses The Power Of Cold To Block Pain 5/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In The Nordic Countries 5/1/2014
Gilead Sciences, Inc. (GILD)'s Solvadi Strikes Again: $1,000 A Pill Rattles Medicaid Programs 4/30/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Release: Anoro™ Ellipta® Now Available In The U.S. For Treatment Of COPD 4/28/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
PuriCore Launches NovaZo Wound Hydrogel For Equine And Companion Animals 4/23/2014
NovaBay Pharmaceuticals, Inc. (NBY) Introduces Advanced I-Lid Cleanser For Cleaning Eyelids And Skin Around The Eye 4/23/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Initiation Of An Expanded Access Program To Provide Firdapse At No Cost To U.S. Patients With Lambert-Eaton Myasthenic Syndrome 4/23/2014
Zogenix, Inc. (ZGNX) Responds To Governor's Action Singling Out Zohydro™ ER In Massachusetts, Encourages Officials To Consider Patient Needs And Effective Class-Wide Measures 4/23/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg 4/23/2014
Oculus Innovative Sciences, Inc. (OCLS)' Partner, More Pharma Corporation, Launches Microcyn®-Based Oral And Throat Infection Treatment Product In Mexico 4/22/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Adenosine Injection, USP 4/21/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Mylan Inc. (MYL) Launches First Generic ORTHO EVRA® Patch 4/17/2014
Dr. Reddy's Laboratories Ltd. (RDY)’ Announces The Launch Of Eszopiclone Tablets C-IV 4/16/2014
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic RENVELA® 4/16/2014
Apricus Biosciences (APRI)' Partner In The United Kingdom Accepts First Shipment Of Vitaros® 4/16/2014
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Lunesta® Tablets In The United States 4/15/2014
Ferring Pharmaceuticals Release: UK National Institute for Clinical Excellence (NICE) Guidance Recommends FIRMAGON® (Degarelix) For The Treatment Of Advanced Hormone-Dependent Prostate Cancer Only In People With Spinal Metastases Who Present With Signs Or Symptoms Of Impending Spinal Cord Compression (ISCC) 4/15/2014
FDA Extends Market Exclusivity Six Months For BioMarin Pharmaceutical Inc. (BMRN)'s Rare Disease Therapy KUVAN® (Sapropterin Dihydrochloride) Powder For Oral Solution And Tablets 4/14/2014
Doctors Welcome Hepatitis C Drug Rivals, Gilead Sciences, Inc. (GILD) Still Leads 4/11/2014
Ironwood Pharmaceuticals (IRWD) And Forest Laboratories, Inc. (FRX) Launch New Direct-To-Consumer Awareness Campaign For LINZESS® 4/10/2014
AbbVie (ABBV) Announces Availability Of New Advanced Parkinson's Treatment In Canada 4/10/2014
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Plans To Gradually Phase-Out Of Ranbaxy Laboratories (RANBAXY.BO)-Branded Drugs In U.S. 4/9/2014
Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force Gilead Sciences, Inc. (GILD) To Cut Price Of Sovaldi 4/9/2014
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014
ULURU Inc. Release: Initial Pharmacoeconomic Data Demonstrates Cost Benefits Of Altrazeal® 4/7/2014
Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe 4/7/2014
Zogenix, Inc. (ZGNX) Statement: Let's Get The Facts Straight About Zohydro ER 4/3/2014
Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma 4/2/2014
Swedish Orphan Biovitrum Assumes Direct Responsibility For Orfadin® (Nitisinone) In U.S. And Canada And Introduces Orfadin4U™ 4/1/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Adenosine Injection, USP 3/31/2014
Mission Pharmacal Company Introduces New And Improved Version Of Top-Selling Prescription Prenatal Vitamin, Citranatal Harmony® 3/28/2014
Genzyme Corporation (GENZ) Release: U.S. Prescribing Information For Thyrogen Revised To Include Use Of Wider Range Of Radioiodine In Patients 3/27/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets 3/27/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014
Sanofi (France) (SAN.PA) Release: National Institute for Clinical Excellence (NICE) Rejects Life-Extending Bowel Cancer Drug Two Weeks After Scottish Approval 3/25/2014
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo 3/24/2014
UK Cancer Drugs Fund Adds Roche (RHHBY), Celgene Corporation (CELG) And Exelixis, Inc. (EXEL) Drugs 3/24/2014
Quinnova Pharmaceuticals, Inc. Announces The Launch Of ECOZA™ (Econazole Nitrate) Topical Foam, 1% 3/18/2014
National Institute of Clinical Research Turns Down Celgene (CELG)'s Revlimid 3/17/2014
NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe 3/17/2014
H. Lundbeck A/S (LUN.CO) And Otsuka Pharmaceutical Co., Ltd. Initiate European Launch Of Abilify Maintena® (Aripiprazole), A Once-Monthly Formulation For The Treatment Of Schizophrenia 3/17/2014
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug 3/13/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Receives Notice That Second Indication For AMITIZA For Opioid-Induced Constipation Is Not Approved By Medicines And Healthcare Products Regulatory Agency In U.K. 3/13/2014
Bacterin International, Inc. Announces The Launch Of OsteoSTX, A Novel Biologic Product 3/13/2014
French Competition Regulator Probes Roche (RHHBY), Novartis AG (NVS) 3/12/2014
Perrigo Company (PRGO) Announces Launch Of Generic Version Of Neptazane™ (Methazolamide) Tablets 3/12/2014
Bayer HealthCare (BAY) Launches Eight New Products To Treat Flea And Tick Infestations 3/12/2014
Mylan Inc. (MYL) Launches Naloxone Hydrochloride Injection 3/12/2014
Antares Pharma, Inc. (ATRS) Announces LEO Pharma’s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis 3/10/2014
Novartis AG (NVS) Muscle Drug Sales May Reach $4 Billion, According To MorphoSys AG 3/7/2014
McNeil Consumer Healthcare Release: The Makers of ZYRTEC® Launch New Dissolve Tabs 3/6/2014
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. (ALXN) To Justify Cost Of Drug 3/5/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Moxifloxacin Hydrochloride Tablets 3/5/2014
Citron Research Says Prized Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Drug Missing Key Ingredient 3/4/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The U.S. Commercial Launch Of ADASUVE® By Teva Pharmaceutical Industries Limited (TEVA) 3/3/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches ADASUVE® In U.S. 3/3/2014
Dendreon Corporation (DNDN) Announces Plans To Make PROVENGE® Commercially Available In Europe 3/3/2014
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs 2/28/2014
Groups Urge FDA To Halt Launch Of Zogenix, Inc. (ZGNX)'s Zohydro Pain Drug 2/28/2014
Easton Pharmaceuticals (OP: EAPH) Announces The Launching Of Hempstral SA, A New Hemp Based Anti Ageing Product & Reaches Marketing Develop And Distribution Agreement With Hemplifetoday.Com 2/28/2014
Cell Therapeutics, Inc. (CTIC) Release: National Institute for Clinical Excellence (NICE) Publishes Final Guidance On PIXUVRI® (pixantrone) 2/27/2014
Records Show Boehringer Ingelheim Corporation Did Not Disclose Pradaxa Analysis To FDA 2/26/2014
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Bexsero®: First Vaccine To Prevent Meningococcal Serogroup B (MenB) Now Available In Canada 2/26/2014
Essex Medipharma To Distribute Pfizer Inc. (PFE) Glaucoma Eye Drops In China 2/25/2014
National Institute for Clinical Excellence (NICE) Turns Down Biogen Idec, Inc. (Massachusetts) (BIIB)'s Oral MS Drug 2/24/2014
Gilead Sciences, Inc. (GILD) Close To Dominating Second Multibillion Market With Solvadi 2/24/2014
Forest Laboratories, Inc. (FRX) Launches STRIDE Patient Support Program For COPD Franchise Products Tudorza® Pressair® And Daliresp® 2/24/2014
Fresenius Kabi AG Release: Acetylcysteine Solution, USP 20% In 4 ML Vials Now Available 2/24/2014
Amarin Corporation PLC (AMRN) Announces FDA Award Of Three-Year Exclusivity For Vascepa® (Icosapent Ethyl) Capsules 2/24/2014
Afaxys Pharmaceuticals Release: Aubra™ Coverage Expands Significantly 2/21/2014
Innovus Pharma Announces Availability Of Ejectdelay™ For Premature Ejaculation In The United States 2/21/2014
Axxess Pharma, Inc. Announces Launch Of US TapouT Sales: Initial PO Through NPI, Nutritional Products International, A Leading Brand Management Company 2/18/2014
Double-Crane Pharmaceutical Co., Ltd. To Distribute Sagent Pharmaceuticals, Inc. Pediatric Drug In China 2/14/2014
Alvogen Launches Inflectra In Europe With Hospira, Inc. 2/13/2014
Gilead Sciences, Inc. (GILD) COO: Analysts' Sky-High Hep C Drug View "Not Unreasonable" 2/12/2014
Jazz Pharmaceuticals plc (JAZZ) Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 2/12/2014
FDA Panel Votes Down Heart Safety Claim For Aleve 2/11/2014
Zogenix, Inc. Provides Update On Zohydro™ ER (Hydrocodone Bitartrate) Launch Readiness Plans 2/11/2014
FDA Panel To Weigh Painkiller' Cardiac Risk 2/10/2014
Arena Pharmaceuticals, Inc. (ARNA) Reports Coverage For BELVIQ® (Lorcaserin Hcl) CIV Now Greater Than 50% Of Insured Commercial Lives 2/10/2014
Eisai Inc. (ESALF.PK) Reports Improved Patient Access For BELVIQ® (lorcaserin HCI) CIV 2/10/2014
Mallinckrodt Pharmaceuticals (MNK)’ New Drug Available To Patients 2/10/2014
Nuvo Research Inc. (NRI.TO) Announces The U.S. Commercial Launch Of PENNSAID® 2% By Mallinckrodt Pharmaceuticals (MNK) 2/10/2014
pSivida Corp (PSDV) Announces ILUVIEN® For DME Accepted By National Health Service Scotland 2/10/2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options Of LANOXIN® For Cardiac Patients With Mild-To-Moderate Heart Failure 2/7/2014
All Physicians In Switzerland Are Now Able To Prescribe Sucampo Pharmaceuticals, Inc. (SCMP)'s AMITIZA® For Chronic Idiopathic Constipation 2/6/2014
Sanofi (France) (SAN.PA)'s Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without A Prescription In The U.S. 2/4/2014
Mylan Inc. (MYL) Launches First Trastuzumab Biosimilar, Hertraz™, In India 2/3/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Hepatitis C Drug Sets Off Payer Revolt 1/30/2014
Bayer HealthCare (BAY)'s Annihilator™ Polyzone® Makes Insect Control Easy All Season Long 1/29/2014
Mylan Inc. (MYL) Launches Generic Prandin® Tablets 1/24/2014
Takeda Pharmaceuticals And Lundbeck Inc. (LUN.CO) Announce Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In Pharmacies 1/23/2014
Avion Pharmaceuticals Announces The Launch Of Prenate® Enhance And Prenate® Restore 1/23/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014
Eisai Company, Ltd. (ESALY.PK) Announces Launch Of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-Acting Antimicrobial Agent Etak 1/22/2014
American Regent, Inc. Expands Promotional Campaign For Iron Deficiency Anemia Drug Injectafer® (Ferric Carboxymaltose Injection) 1/22/2014
Ipsen (IPN.PA) Implements A New Governance In The United States To Prepare For The Launch Of Somatuline® In Oncology 1/22/2014
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/21/2014
H. Lundbeck A/S (LUN.CO)'s Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In U.S. Pharmacies 1/21/2014
Vectura Group plc (VEC.L)'s AirFluSal® Forspiro® Launched In Denmark 1/20/2014
Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma 1/17/2014
Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children 1/17/2014



//-->